Skip to content
Screener

EyePoint, Inc. EYPT Other operating expenses

Other operating expenses at other companies

Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$59.78M+1.2%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$76.67M+42.9%
KLR
Kalaris TherapeuticsKLRS
$11.83M+14.3%
HRO
HarrowHROW
$61.37M+70.0%
Bausch + Lomb logo
Bausch + LombBLCO
-$25M-13.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$27.18M-8.9%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.11B+51.9%
Enterprise value$1.02B+49.6%
P/S396.6×+383×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Research and development83,61455,498155,757114,072
Sales and marketing31353470
General and administrative14,24211,86229,48525,738
Total operating expenses97,88767,560185,809140,850
Loss from operations(97,380)(62,227)(184,606)(111,064)
Other (expense) income:
Interest and other income, net2,9102,8945,2546,536
Total other income, net2,9102,8945,2546,536

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s other operating expenses?
EyePoint, Inc. (EYPT) reported other operating expenses of $97.89M in Q2 2026.
How has EyePoint, Inc.'s other operating expenses changed year-over-year?
EyePoint, Inc.'s other operating expenses increased by 44.9% year-over-year, from $67.56M to $97.89M.
What is the long-term trend for EyePoint, Inc.'s other operating expenses?
Over 4 years (2021 to 2025), EyePoint, Inc.'s other operating expenses has grown at a 31.4% compound annual growth rate (CAGR), from $92.22M to $274.81M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Ask your AI about EyePoint, Inc.'s other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude